Loading, Please Wait...

CST: 23/09/2019 10:22:57   

Harrow Health to Attend Lake Street’s 3rd Annual Best Ideas Growth Conference September 12, 2019

27 Days ago

NASHVILLE, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that it will be attending Lake Street’s 3rd Annual BIG Conference September 12, 2019.

Mark L. Baum, CEO, and Andrew Boll, CFO, will be available for one-on-one meetings with investors to provide an update on the company’s business on Thursday September 12th, 2019 at the Parker New York Hotel in New York, NY. 

Please contact your Lake Street representative to arrange a meeting.  Alternatively, to receive additional information, request an invitation or to schedule a one-on-one meeting, you may also email conference@lakestreetcm.com or call 612-326-1305.

About Lake Street Capital Markets

Founded in 2012, Lake Street Capital Markets is a full-service boutique investment bank focused on dynamic high-growth companies and sectors of the economy. Our research enables institutional investors to understand emerging secular trends and identify innovative companies best positioned to benefit. Lake Street provides access to capital, mergers and acquisitions advice, and strategic counsel with a focus on building relationships to unlock value and growth. At the core of everything we do is our commitment to providing informed advice and exceptional service to our clients. For more information visit http://www.lakestreetcapitalmarkets.com/

About Harrow Health

Harrow Health, Inc. (NASDAQ: HROW) owns a portfolio of healthcare businesses, including one of the nation’s leading ophthalmology pharmaceutical businesses, ImprimisRx.  The company holds large equity positions in Eton Pharmaceuticals, Surface Pharmaceuticals, Melt Pharmaceuticals, Mayfield Pharmaceuticals, Radley Pharmaceuticals, and Stowe Pharmaceuticals, Inc., all companies founded as subsidiaries of Harrow Health.  The Company also owns royalty rights in certain 505(b)(2) drug candidates being developed by Surface, Melt, Mayfield and Radley.  Harrow intends to create, invest in and grow paradigm shifting health care businesses that put patients first.  For more information about Harrow Health, please visit the Investor Relations section of the corporate website by clicking here.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward-looking statements." Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties which may cause results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include our ability to make commercially available our compounded formulations and technologies in a timely manner or at all; physician interest in prescribing our formulations; risks related to our compounding pharmacy operations; our ability to enter into other strategic alliances, including arrangements with pharmacies, physicians and healthcare organizations for the development and distribution of our formulations; our ability to obtain intellectual property protection for our assets; our ability to accurately estimate our expenses and cash burn, and raise additional funds when necessary; risks related to research and development activities; the projected size of the potential market for our technologies and formulations; unexpected new data, safety and technical issues; regulatory and market developments impacting compounding pharmacies, outsourcing facilities and the pharmaceutical industry; competition; and market conditions. These and additional risks and uncertainties are more fully described in Harrow Health’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Such documents may be read free of charge on the SEC's web site at www.sec.gov. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Except as required by law, Harrow Health undertakes no obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they are made, or to reflect the occurrence of unanticipated events.

Investor Contact:
Jon Patton
jpatton@harrowinc.com
858-704-4587

Source: Harrow Health, Inc.

Is your business listed correctly on America’s largest city directory network of 1,000 portals?